Insights

In the biotech space, innovation alone isn’t enough — success hinges on proving both clinical and economic value. This blog explores why Health Economics and Outcomes Research (HEOR) should be a strategic pillar, not a back-office function, and how companies can embed it across the drug development lifecycle to accelerate market access and adoption.

Discover how AI, including Generative AI, is transforming the MedTech industry—from accelerating product development to enabling personalized, predictive healthcare. Explore real-world applications across devices, diagnostics, and digital health solutions, and see how Agilisium empowers MedTech innovation with advanced data and AI capabilities.

In the rapidly evolving landscape of therapeutic and diagnostic innovation, antibody discovery stands at the forefront—powered by the precision and speed of artificial intelligence. As researchers navigate complex data, diverse targets, and the urgent need for efficiency, AI is emerging as a game-changer in identifying, designing, and optimizing monoclonal antibodies. This blog explores how AI is accelerating breakthroughs and reshaping the future of antibody development.